help button home button Endocrine Society JCEM ENDO 08
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mariotti, S.
Right arrow Articles by Pinchera, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mariotti, S.
Right arrow Articles by Pinchera, A.

Journal of Clinical Endocrinology & Metabolism, Vol 71, 661-669, Copyright © 1990 by Endocrine Society


ARTICLES

Antithyroid peroxidase autoantibodies in thyroid diseases

S Mariotti, P Caturegli, P Piccolo, G Barbesino and A Pinchera
Istituto di Endocrinologia, Universita di Pisa, Italy.

Thyroid microsomal antibodies (anti-M Ab) have been recently proven to be directed to thyroid peroxidase (TPO). Methods to detect anti-TPO antibodies (anti-TPO Ab) employing purified antigen have been developed, but the available information on the clinical usefulness of this technique is still limited to small patient series. In the present investigation anti-TPO Ab were assayed by a newly developed monoclonal antibody-assisted RIA in a large number (n = 715) of subjects, including 119 normal controls and 596 patients with different autoimmune or nonautoimmune thyroid disease: Anti-TPO Ab were detected in 10 of 119 (8.4%; range, 11-210 U/mL) normal controls, 134 of 181 (74%; range, 11-74.000 U/mL) patients with Graves' disease, all but 1 of 144 (99.3%; range, 11-90.000 U/mL) with Hashimoto's thyroiditis (n - 98) or idiopathic myxedema (n = 46), 20 of 180 (11.1%; range, 11-6.700 U/mL) with miscellaneous nonautoimmune thyroid diseases, 16 of 83 (19.2%; range, 11-6.600 U/mL) patients with differentiated thyroid carcinoma, and in none of 8 patients with subacute thyroiditis. The highest anti-TPO Ab concentrations were found in untreated hypothyroid Hashimoto's thyroiditis, but no simple relationship between anti-TPO Ab levels and thyroid function was observed. Anti-TPO Ab significantly decreased in patients with Graves' disease after treatment with methimazole and in those with hypothyroid Hashimoto's thyroiditis or idiopathic myxedema during L-T4 administration. A highly significant positive correlation (r = 0.979; P less than 0.001) was found between anti-M Ab titers by passive hemagglutination (PH; available in 650 sera) and the corresponding average anti-TPO Ab by RIA; discrepant results were almost exclusively limited to sera with negative or low (1:100-1:400) anti-M Ab titers. Analysis of these discrepant data indicated higher autoimmune disease specificity and sensitivity of anti- TPO Ab RIA tests compared to anti-M Ab by PH. Absorption studies showed that interference of anti-Tg Ab was responsible for anti-M Ab-positive tests in occasional anti-TPO Ab-negative/anti-M Ab-positive sera from autoimmune thyroid disease patients. Anti-TPO Ab determination by RIA was unaffected by circulating thyroglobulin concentrations up to more than 10,000 ng/mL. In conclusion, anti-TPO Ab assay by monoclonal antibody-assisted RIA appears to be more sensitive and specific for thyroid autoimmune diseases than anti-M Ab determination by PH. Since the assay is easy to perform and employs only tracer amounts of purified antigen, these characteristics should allow its rapid diffusion to the clinical routine.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Li, D. Teng, Z. Shan, X. Teng, H. Guan, X. Yu, C. Fan, W. Chong, F. Yang, H. Dai, et al.
Antithyroperoxidase and Antithyroglobulin Antibodies in a Five-Year Follow-Up Survey of Populations with Different Iodine Intakes
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1751 - 1757.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S. Zoncu, F. Pigliaru, C. Putzu, L. Pisano, S. Vargiu, M. Deidda, S. Mariotti, and G. Mercuro
Cardiac function in borderline hypothyroidism: a study by pulsed wave tissue Doppler imaging
Eur. J. Endocrinol., April 1, 2005; 152(4): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Marinò, L. Chiovato, J. A. Friedlander, F. Latrofa, A. Pinchera, and R. T. McCluskey
Serum Antibodies against Megalin (GP330) in Patients with Autoimmune Thyroiditis
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2468 - 2474.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. McIntosh, M. S. Asghar, E. H. Kemp, P. F. Watson, A. Gardas, J. P. Banga, and A. P. Weetman
Analysis of Immunoglobulin G{kappa} Antithyroid Peroxidase Antibodies from Different Tissues in Hashimoto's Thyroiditis
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3818 - 3825.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. M. Dayan and G. H. Daniels
Chronic Autoimmune Thyroiditis
N. Engl. J. Med., July 11, 1996; 335(2): 99 - 107.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society